AK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.923000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.954600E-01
Normal-vs-Stage2
5.330600E-01
Normal-vs-Stage3
8.736400E-01
Normal-vs-Stage4
3.338800E-01
Stage1-vs-Stage2
5.212600E-01
Stage1-vs-Stage3
7.644200E-01
Stage1-vs-Stage4
5.208600E-01
Stage2-vs-Stage3
3.179200E-01
Stage2-vs-Stage4
7.909200E-01
Stage3-vs-Stage4
4.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.547000E-01
Normal-vs-AfricanAmerican
3.157200E-01
Normal-vs-Asian
3.236800E-01
Caucasian-vs-AfricanAmerican
3.067400E-01
Caucasian-vs-Asian
1.773380E-01
AfricanAmerican-vs-Asian
9.977600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.171800E-01
Normal-vs-Female
5.795600E-01
Male-vs-Female
9.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.905200E-01
Normal-vs-Age(41-60Yrs)
2.935400E-01
Normal-vs-Age(61-80Yrs)
7.453800E-01
Normal-vs-Age(81-100Yrs)
5.519600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.099000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.028400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.732000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.903500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.083000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.530800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.221200E-01
Normal-vs-Daily Drinker
5.486800E-01
Normal-vs-Weekly Drinker
9.615000E-01
Normal-vs-Occasional Drinker
1.410020E-01
Normal-vs-Social Drinker
7.335600E-01
Non Drinker-vs-Daily Drinker
2.166400E-01
Non Drinker-vs-Weekly Drinker
9.249600E-01
Non Drinker-vs-Occasional Drinker
1.375830E-02
Non Drinker-vs-Social Drinker
7.755600E-01
Daily Drinker-vs-Weekly Drinker
2.847800E-01
Daily Drinker-vs-Occasional Drinker
3.445400E-01
Daily Drinker-vs-Social Drinker
3.281800E-01
Weekly Drinker-vs-Occasional Drinker
2.312000E-02
Weekly Drinker-vs-Social Drinker
7.096600E-01
Occasional Drinker-vs-Social Drinker
2.141900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.732200E-01
Normal-vs-Grade 2
8.054400E-01
Normal-vs-Grade 3
8.351400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.542920E-03
Grade 1-vs-Grade 3
2.670500E-02
Grade 1-vs-Grade 4
9.732200E-01
Grade 2-vs-Grade 3
4.812200E-01
Grade 2-vs-Grade 4
8.054400E-01
Grade 3-vs-Grade 4
8.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.368200E-01
Normal-vs-NonDiabetic
6.016200E-01
Diabetic-vs-NonDiabetic
6.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.548770E-01
Normal-vs-NoPancreatitis
7.080200E-01
Pancreatitis-vs-NoPancreatitis
3.196200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.765400E-01
Normal-vs-N1
5.660800E-01
N0-vs-N1
9.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.881200E-01
Normal-vs-TP53-NonMutant
9.805000E-01
TP53-Mutant-vs-TP53-NonMutant
2.2085000000005E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
